Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome

Novartis logo

Novartis

Status and phase

Completed
Phase 4

Conditions

Metabolic Syndrome

Treatments

Drug: Fluvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00138528
CXUO320BDE30

Details and patient eligibility

About

Other effects of fluvastatin are investigated in German patients with metabolic syndrome.

Enrollment

55 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent
  • Male and female patients, aged between 18 and 75 years
  • Metabolic syndrome according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII)

Exclusion criteria

  • History of heart failure
  • HIV positive
  • Stroke

Other protocol defined inclusion and exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems